RUBYLYN HILARIO: Open Payments
NPI 1952862104 · ELGIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,669 in 213 payments from 32 companies in 2025. Trend: 2023 $3,798 · 2024 $4,433 · 2025 $4,669
Food & beverage: $4,669
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $531 |
| Dexcom, Inc. | 11 | $525 |
| Amgen Inc. | 24 | $490 |
| Lilly USA, LLC | 24 | $433 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $300 |
| Corcept Therapeutics | 14 | $294 |
| Xeris Pharmaceuticals, Inc. | 14 | $238 |
| Amneal Pharmaceuticals LLC | 14 | $200 |
| RECORDATI_RARE_DISEASES_INC. | 8 | $196 |
| IBSA Pharma Inc. | 12 | $188 |
Products named: Dexcom G6 Transmitter, JARDIANCE, Korlym, MOUNJARO, Wegovy, UNITHROID, ISTURISA, RECORLEV.
Industry payments across IL — which companies pay providers there.
